Vimarsana
Biggest News Aggregation in the World

Page 3 - Zai Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zai Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zai Labs Today - Breaking & Trending Today

2 Growth Stocks With Incredible Potential in the Next 5 Years - Vimarsana News

2 Growth Stocks With Incredible Potential in the Next 5 Years

Neither is profitable, but both could be on the verge of massive booms in revenue.

Source: fool.com
Tumor-Zapping Device Scores in Pivotal Study, Sends Shares of Novocure Soaring - Vimarsana News

Tumor-Zapping Device Scores in Pivotal Study, Sends Shares of Novocure Soaring

Novocure’s electrical field-producing medical device, in combination with standard drug therapies, improved overall survival in a pivotal study that enrolled patients with advanced non-small cell lung cancer. The medtech company now plans to seek regulatory approvals.

Novocure shares soar on positive lung cancer data - Vimarsana News

Novocure shares soar on positive lung cancer data

BioPharma

Zai Labs Stock: Biopharma's Alibaba, But Better (NASDAQ:ZLAB) - Vimarsana News

Zai Labs Stock: Biopharma's Alibaba, But Better (NASDAQ:ZLAB)

Zai Labs is a relative new entrant to the Chinese pharma space and has multiple approvals and a large clinical pipeline. Read more on ZLAB here.

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors - Vimarsana News

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity ap...